Eric Bergeron (B.Eng., M.Sc.A, Ph.D.)
Eric Bergeron (B.Eng., M.Sc.A, Ph.D.)
Dawson College
Verified email at polymtl.ca
Title
Cited by
Cited by
Year
Cell responses to bone morphogenetic proteins and peptides derived from them: Biomedical applications and limitations
H Senta, H Park, E Bergeron, O Drevelle, D Fong, E Leblanc, F Cabana, ...
Cytokine & Growth Factor Reviews 20 (3), 213-222, 2009
1292009
BMP‐9‐induced muscle heterotopic ossification requires changes to the skeletal muscle microenvironment
E Leblanc, F Trensz, S Haroun, G Drouin, É Bergeron, CM Penton, ...
Journal of Bone and Mineral Research 26 (6), 1166-1177, 2011
952011
Differentiation of preosteoblasts using a delivery system with BMPs and bioactive glass microspheres
E Bergeron, ME Marquis, I Chretien, N Faucheux
Journal of Materials Science: Materials in Medicine 18 (2), 255-263, 2007
932007
Bone cells-biomaterials interactions
ME Marquis, E Lord, E Bergeron, O Drevelle, H Park, F Cabana, H Senta, ...
Frontiers in Bioscience 14 (3), 1023-1067, 2009
712009
Murine preosteoblast differentiation induced by a peptide derived from bone morphogenetic proteins-9
E Bergeron, H Senta, A Mailloux, H Park, E Lord, N Faucheux
Tissue Engineering Part A 15 (11), 3341-3349, 2009
602009
Bone repair: New developments in growth factor delivery systems and their mathematical modeling
MA Lauzon, É Bergeron, B Marcos, N Faucheux
Journal of Controlled Release 162 (3), 502-520, 2012
582012
Sanguinarine induces apoptosis of human osteosarcoma cells through the extrinsic and intrinsic pathways
H Park, E Bergeron, H Senta, K Guillemette, S Beauvais, R Blouin, ...
Biochemical and Biophysical Research Communications 399 (3), 446-451, 2010
562010
Hyperspectral reflected light microscopy of plasmonic Au/Ag alloy nanoparticles incubated as multiplex chromatic biomarkers with cancer cells
S Patskovsky, E Bergeron, D Rioux, M Simard, M Meunier
Analyst 139 (20), 5247–5253, 2014
472014
The evaluation of ectopic bone formation induced by delivery systems for bone morphogenetic protein-9 or its derived peptide
E Bergeron, E Leblanc, O Drevelle, R Giguère, S Beauvais, G Grenier, ...
Tissue Engineering Part A 18 (3-4), 342-352, 2012
462012
Gold nanoparticle-assisted all optical localized stimulation and monitoring of Ca2+ signaling in neurons
F Lavoie-Cardinal, C Salesse, E Bergeron, M Meunier, P De Koninck
Scientific Reports 6, 20619, 2016
422016
Wide‐field hyperspectral 3D imaging of functionalized gold nanoparticles targeting cancer cells by reflected light microscopy
S Patskovsky, E Bergeron, D Rioux, M Meunier
Journal of Biophotonics 8 (5), 401-407, 2015
402015
Hyperspectral darkfield microscopy of PEGylated gold nanoparticles targeting CD44‐expressing cancer cells
S Patskovsky, E Bergeron, M Meunier
Journal of Biophotonics 8 (1-2), 162-167, 2015
402015
Effect of functionalized polycaprolactone on the behaviour of murine preosteoblasts
O Drevelle, E Bergeron, H Senta, MA Lauzon, S Roux, G Grenier, ...
Biomaterials 31 (25), 6468-6476, 2010
392010
Cell-specific optoporation with near-infrared ultrafast laser and functionalized gold nanoparticles
E Bergeron, C Boutopoulos, R Martel, A Torres, C Rodriguez, J Niskanen, ...
Nanoscale 7 (42), 17836-17847, 2015
322015
Short-term effects of adhesion peptides on the responses of preosteoblasts to pBMP-9
ME Marquis, E Lord, E Bergeron, L Bourgoin, N Faucheux
Biomaterials 29 (8), 1005-1016, 2008
232008
Cell perforation mediated by plasmonic bubbles generated by a single near infrared femtosecond laser pulse
C Boutopoulos, E Bergeron, M Meunier
Journal of Biophotonics 9 (1-2), 26-31, 2016
182016
Effect of BMP-9 and its derived peptide on the differentiation of human white preadipocytes
E Lord, E Bergeron, H Senta, H Park, N Faucheux
Growth Factors 28 (3), 149-156, 2010
172010
Early fibrillin-1 assembly monitored through a modifiable recombinant cell approach
D Hubmacher, E Bergeron, C Fagotto-Kaufmann, LY Sakai, DP Reinhardt
Biomacromolecules 15 (4), 1456-1468, 2014
142014
Combination of synthetic peptides derived from bone morphogenetic proteins and biomaterials for medical applications
H Senta, E Bergeron, O Drevelle, H Park, N Faucheux
The Canadian Journal of Chemical Engineering 89 (2), 227-239, 2011
142011
Preventing MEK1 activation influences the responses of human osteosarcoma cells to bone morphogenetic proteins 2 and 9
H Park, O Drevelle, A Daviau, H Senta, E Bergeron, N Faucheux
Anti-Cancer Drugs 24 (3), 278-290, 2013
102013
The system can't perform the operation now. Try again later.
Articles 1–20